RACHEL DUCHARME: Open Payments
NPI 1407443252 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$943 in 52 payments from 9 companies in 2025. Trend: 2023 $165 · 2024 $669 · 2025 $943
Food & beverage: $943
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $318 |
| PFIZER INC. | 11 | $176 |
| Novo Nordisk Inc | 7 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Amgen Inc. | 3 | $56 |
| SHIELD THERAPEUTICS INC | 2 | $45 |
| Exact Sciences Corporation | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: VRAYLAR, NURTEC ODT, QULIPTA, UBRELVY, Wegovy, CAPLYTA, REXULTI, ELIQUIS.
Industry payments across GA — which companies pay providers there.
